Financials
Financial year 2024
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
Gross margin
€ 2.9 million
▲ 701% vs 2023
Profit
Caution€ -11 million
▼ 90% vs 2023
Debts
High€ 6.1 million
▼ 34% vs 2023
PDC line Pharma from Liège, company number BE0657842221, closed financial year 2024 with a result of € -11 million after tax. For that financial year PDC line Pharma recorded a gross margin of € 2.9 million and equity of € -7.8 million. Compared with financial year 2023, the result moved from € -5.8 million to € -11 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2025.
What happened at PDC line Pharma?
What happened at PDC line Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 11 million. filed late Source: NBB ↗
- NOSHAQ PARTNERS SC stepped down as director. NBB
- Lee SANGWOO stepped down as director. NBB
- Mondher MAHJOUBI stepped down as director. NBB
- Alain HERRERA stepped down as director. NBB
- JPP CONSULTING SRL stepped down as director. NBB
- Joël PLUMAS stepped down as director. NBB
- SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT SA stepped down as director. NBB
In short
From € 5.3 million loss in 2021 to € 11 million loss in 2024.
On average € 129,700 of value added per employee in 2024.
A new publication or filing at PDC line Pharma? We notify you, reason included.
Follow PDC line PharmaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of PDC LINE PHARMA SAS itself.
Directors
According to the 2024 annual accounts
Director · represented by Marleen LIMBOURG, Marleen Limbourg, Patrick STRAGIER
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE +174 more
since 2021 · until 2025
Lee SANGWOO
Director
since 2021 · until 2025
Mondher MAHJOUBI
Chairman of the board
since 2021 · until 2025
Alain HERRERA
Director
since 2021 · until 2025
Director · represented by Jean-Paul PRIEELS
Also active at: CURAVAC EUROPE, ConvEyXo, XomeXBio +1 more
since 2021 · until 2025
Joël PLUMAS
Director
since 2021 · until 2025
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT SA
Director · represented by François FONTAINE
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale +62 more
since 2021 · until 2025
Laurent LEVY
Director
since 2021 · until 2025
Managing director · represented by Eric HALIOUA
since 2021 · until 2025
Establishments
Establishment units
Physical locations of this company
Rue Louvrex 55-57
4000 Liège
Boulevard de Patience et Beaujonc 3 box 6
4000 Liège
Active since 1 July 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
EXIMPA
LM GESTION
€ 305,980 gross margin · 2024
LASERFLASH
€ 1.7 million gross margin · 2023
Agence locale pour l'Emploi de Villers-le-Bouillet
SPARX INDUSTRIES
€ 19.7 million revenue · 2024
+15 more
Details
- Company number
- 0657.842.221
- VAT number
- BE 0657.842.221
- Registered office
- Rue Louvrex 55-57, 4000 Liège
- Names & denominations
- PDC line Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Vrijwillige ontbinding – vereffening
- Start date
- 30 June 2016
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied